Issues: Vax Specific

Anthrax

Hepatitis B

Hib

Influenza

Lyme Disease
Meningococcal

MMR    

Polio

Rotavirus

● Smallpox

Tdap/Td

Varicella

Yellow Fever

 

Issues: Misc

Exemptions

Legislation 

New Vax Status

Thimerosal

Independent Vax  Safety Board

 

Vaccine Info

2008 Schedule

ACIP Recs

Components
IOM Reports

● Vax Injury Comp Program
Manufacturer Links

Package Inserts

Reporting AEs

Thimerosal Table

VAERS

VISs

 

Links
 

Search
 

About IVS

Faculty Biographies

Publications

Donations

 

Email IVS

 

Disclaimers & Privacy
 

 

Institute for Vaccine Safety

Johns Hopkins Bloomberg School of Public Health

615 N. Wolfe Street

Room W5041

Baltimore, MD 21205

www.vaccinesafety.edu

 

 

 

 

Components of
Japanese Encephalitis Vaccine
Excipients Table
Allergens Table
Components Table
 

Indication

Induction of active immunity against the causative virus among people who plan to reside in or travel to areas where JE is endemic or epidemic during a transmission season.

Proprietary Name

JE-VAX

Manufacturer

Biken, distributed by sanofi pasteur

Viability

Inactivated

Microorganism

Single-stranded RNA virus, family Flaviviridae

Dose

1.0 mL

Route

Subcutaneous

Dose form

Powder for suspension

Appearance

White caked powder - after reconstitution, colorless, transparent liquid

Concentration

Nitrogen, 2-3 mcg/dose

Preservatives

Thimerosal, 0.007%

Adjuvant

None

Excipients

Formaldehyde, < 100 mcg

Allergens

Mouse-serum protein, < 50 ng - no myelin basic protein can be detected at the detection threshold of the assay (< 2 ng/mL)

Gelatin, 500 mcg

Thimerosal, 0.007%

Media

Prepared by inoculating mice intracerebrally

Packaging

Single dose vial + diluent

10-dose vial + diluent

Routine Storage

2 to 8° C

Do not freeze

updated November 2005

This page was last updated on January 23, 2008

© 2005 Institute for Vaccine Safety